companydata.dkcompanydata.dk

Wallentin Medical Consulting ApS: Financial statements 2023

CVR: 41746505

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Wallentin Medical Consulting ApS (CVR 41746505) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 654,578 and a net result of DKK 498,557 compared with DKK 467,919 the year before. That is an increase of 5.2% compared with the year before. Equity in the 2023 report amounted to DKK 897,054. The solvency ratio was 74.5%.

Gross Profit
DKK 654,578
Profit/Loss
DKK 498,557
Equity
DKK 897,054
Total Assets
DKK 1,204,783

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-655K499K897K-
2022-622K468K516K-
2021-1.2M953K1.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Wallentin Medical Consulting ApS: The 2022 annual report is outMay 13, 2023

Wallentin Medical Consulting ApS has published its annual report for 2022. Gross profit came to DKK 622,441, and the net result was DKK 467,919.

About Wallentin Medical Consulting ApS

Wallentin Medical Consulting ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2020. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Rikke Søjborg Wallentin. The company is owned by Rikke Søjborg Wallentin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 684,736 and a net result of DKK 527,610 compared with DKK 517,283 the year before. Equity in the 2025 report amounted to DKK 1,684,947.

Source: annual report 2025, Danish Business Authority

Other financial years